Age: 25
Free Agency: 2024 (RFA)
Accrued Seasons: 2
- Height: 6'3"
- Weight: 215
- College: Nebraska
- Entry: 2020 Undrafted Free Agent (Jets)
- 2023 Salary Cap Charge: $940,000 (0.43% of cap)
- 2023 Cash Payout: $940,000 (0.39% of spending)
- 2023 Cash to Cap Ratio: 1.00
- Contract Value: $940,000 ($940,000 APY)
- Fully Guaranteed Money: $0
- Contract Ranking: 216/343 at CB
Current Contract
(SFA, signed 2023)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Cap Number | Cap % | Dead Money & Cap Savings | |||
|---|---|---|---|---|---|---|---|---|
| 2023 | 25 | $940,000 | $940,000 | 0.4% | ||||
| Total | $940,000 | $940,000 | ||||||
Cash Flows
- fully earned money
- unearned or partially earned money
$0.9M
| 2023 | |
|---|---|
| Cash Due | $940,000 |
| Running Cash | $940,000 |
Career Earnings: $1,627,067
Career APY: $542,356
Potential Earnings: $1,661,988
Total Guarantees: $27,500
Largest Cash Payment: $940,000 (2023)
Largest Cap Number: $940,000 (2023)
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Jets | UDFA | Terminated | 2020 | 3 | $2,292,500 | $764,167 | $27,500 | $0 | 0.0% | $0 |
| Jets | Practice | Renegotiated | 2020 | 1 | $197,764 | $197,764 | $0 | $0 | 0.0% | $0 |
| Jets | Practice | Elevated | 2020 | 1 | $142,800 | $142,800 | $0 | $0 | 0.0% | $0 |
| Jets | Practice | Elevated | 2020 | 1 | $170,282 | $170,282 | $0 | $0 | 0.0% | $0 |
| Jets | SFA | Terminated | 2020 | 2 | $1,390,000 | $695,000 | $0 | $430,588 | 31.0% | $430,588 |
| Jets | Practice | Expired | 2021 | 1 | $199,733 | $199,733 | $0 | $199,733 | 100.0% | $199,733 |
| Jets | Practice | Elevated | 2021 | 1 | $165,600 | $165,600 | $0 | $0 | 0.0% | $0 |
| Bears | SFA | Terminated | 2022 | 1 | $825,000 | $825,000 | $0 | $0 | 0.0% | $0 |
| Broncos | Practice | Renegotiated | 2022 | 1 | $207,000 | $207,000 | $0 | $0 | 0.0% | $0 |
| Broncos | Practice | Elevated | 2022 | 1 | $207,000 | $207,000 | $0 | $0 | 0.0% | $0 |
| Broncos | SFA | Terminated | 2022 | 2 | $1,765,000 | $882,500 | $0 | $91,667 | 5.2% | $91,667 |
| Chiefs | SFA | Active | 2023 | 1 | $940,000 | $940,000 | $0 | $0 | 0.0% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Jets | 2 | $905,067 | $452,534 | $630,321 | 0.0% | $294,746 | 0.0% |
| Bears | 0 | $550,000 | $0 | $0 | 0.0% | $550,000 | 0.0% |
| Broncos | 1 | $172,000 | $172,000 | $91,667 | 0.0% | $80,333 | 0.0% |
| Chiefs | 0 | $0 | $0 | $0 | 0.0% | $0 | 0.0% |
Season History
Statistics
| Year | Games Played | Games Inactive | Snaps | Tackles | Negative Plays | Interceptions | Fumbles | TD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Defense | Special | Solo | Assist | Sacks | Yards | TFL | QB Hits | Pass Def. | INT | Yards | Forced | Rec. | Yards | |||
| 2020 | 13 | 0 | 0 | 39.7% | 21.5% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 1 | 0 | 0 | 0.0% | 1.1% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 8 | 0 | 6 | 4.3% | 20.0% | 3 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $188,000 | $940,000 |
| Injury Adjusted | $188,000 | $940,000 |
test
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.